Ralph W. Roach

885 total citations
20 papers, 707 citations indexed

About

Ralph W. Roach is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ralph W. Roach has authored 20 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Ralph W. Roach's work include Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer therapeutics and mechanisms (3 papers). Ralph W. Roach is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer therapeutics and mechanisms (3 papers). Ralph W. Roach collaborates with scholars based in United States and United Kingdom. Ralph W. Roach's co-authors include James A. Neidhart, Leslie R. Laufman, Diane Gochnour, Donn C. Young, Daniel F. Hoth, Michal Segal, Eugene F. May, James S. McCaughan, William J. Hicks and Charles W. Taylor and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The American Journal of Medicine.

In The Last Decade

Ralph W. Roach

20 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph W. Roach United States 13 390 307 123 88 83 20 707
Gary L. Purnell United States 11 328 0.8× 290 0.9× 66 0.5× 66 0.8× 243 2.9× 15 824
Jackson Cundiff United States 10 258 0.7× 327 1.1× 66 0.5× 61 0.7× 102 1.2× 17 871
Michael Eichbaum Germany 19 355 0.9× 231 0.8× 176 1.4× 107 1.2× 163 2.0× 61 965
M. R. Moore United States 16 428 1.1× 287 0.9× 181 1.5× 137 1.6× 228 2.7× 41 1.1k
L. Cerezo Spain 18 520 1.3× 420 1.4× 141 1.1× 86 1.0× 386 4.7× 56 1.2k
C.L. Edwards United States 9 172 0.4× 164 0.5× 163 1.3× 62 0.7× 132 1.6× 19 726
Lawrence W. Margolis United States 9 142 0.4× 287 0.9× 88 0.7× 27 0.3× 110 1.3× 12 689
D Valteau-Couanet France 14 182 0.5× 279 0.9× 204 1.7× 60 0.7× 84 1.0× 28 743
F Eschwège France 15 351 0.9× 248 0.8× 79 0.6× 61 0.7× 323 3.9× 33 882
J. Beck Germany 11 161 0.4× 303 1.0× 182 1.5× 49 0.6× 99 1.2× 18 691

Countries citing papers authored by Ralph W. Roach

Since Specialization
Citations

This map shows the geographic impact of Ralph W. Roach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph W. Roach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph W. Roach more than expected).

Fields of papers citing papers by Ralph W. Roach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph W. Roach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph W. Roach. The network helps show where Ralph W. Roach may publish in the future.

Co-authorship network of co-authors of Ralph W. Roach

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph W. Roach. A scholar is included among the top collaborators of Ralph W. Roach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph W. Roach. Ralph W. Roach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roach, Ralph W., et al.. (2002). Development and Implementation of an Inpatient Acute Palliative Care Service. Journal of Palliative Medicine. 5(1). 93–100. 41 indexed citations
2.
Spiridonidis, C. Harris, Leslie R. Laufman, Timothy M. Moore, et al.. (2001). Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial. Annals of Oncology. 12(1). 89–94. 40 indexed citations
3.
Laufman, Leslie R., C. Harris Spiridonidis, Ralph W. Roach, et al.. (2001). Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial. Annals of Oncology. 12(9). 1259–1264. 46 indexed citations
4.
Taylor, Charles W., Michael LeBlanc, Richard I. Fisher, et al.. (2000). Phase II evaluation of interleukin-4 in patients with non-Hodgkinʼs lymphoma: a Southwest Oncology Group Trial. Anti-Cancer Drugs. 11(9). 695–700. 14 indexed citations
5.
Rytting, Michael, et al.. (1999). Phase II trial of 5-fluorouracil, folinic acid and recombinant α-2a-interferon in patients with advanced colorectal cancer. Anti-Cancer Drugs. 10(6). 519–524. 2 indexed citations
6.
Salmon, S. E., John J. Crowley, S P Balcerzak, et al.. (1998). Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group Study.. Journal of Clinical Oncology. 16(3). 890–896. 45 indexed citations
7.
Malviya, Vinay K., P. Y. Liu, David A. Goldberg, et al.. (1996). A phase II trial of piroxantrone in endometrial cancer. Anti-Cancer Drugs. 7(5). 527–530. 4 indexed citations
8.
Gandara, David R., John Crowley, Robert B. Livingston, et al.. (1993). Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.. Journal of Clinical Oncology. 11(5). 873–878. 121 indexed citations
9.
Custer, Thomas W., et al.. (1992). Determination of hatching date for eggs of black-crowned night-herons, snowy egrets and great egrets. Journal of Field Ornithology. 63(2). 145–154. 13 indexed citations
10.
Zidar, Bernard L., et al.. (1988). A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group Study. Investigational New Drugs. 6(3). 223–226. 70 indexed citations
11.
Laufman, Leslie R., et al.. (1987). Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancer.. Journal of Clinical Oncology. 5(9). 1394–1400. 56 indexed citations
12.
Hicks, William J., et al.. (1987). Phase II study of aclarubicin in non-small cell lung cancer.. PubMed. 71(3). 323–4. 2 indexed citations
13.
Neidhart, James A., Diane Gochnour, Ralph W. Roach, Daniel F. Hoth, & Donn C. Young. (1986). A comparison of mitoxantrone and doxorubicin in breast cancer.. Journal of Clinical Oncology. 4(5). 672–677. 93 indexed citations
14.
Whisler, Ronald L., et al.. (1984). Characterization of multiple immune defects in human malignant lymphoma. Cancer. 53(12). 2628–2634. 11 indexed citations
15.
McCaughan, James S., William J. Hicks, Leslie R. Laufman, Eugene F. May, & Ralph W. Roach. (1984). Palliation of esophageal malignancy with photoradiation therapy. Cancer. 54(12). 2905–2910. 73 indexed citations
16.
Neidhart, James A., Diane Gochnour, Ralph W. Roach, Daniel Young, & Jeffrey A. Steinberg. (1984). A comparative trial of mitoxantrone and doxorubicin in patients with minimally pretreated breast cancer.. PubMed. 11(3 Suppl 1). 11–4. 12 indexed citations
17.
Neidhart, James A., et al.. (1983). Mitoxantrone versus doxorubicin in advanced breast cancer: A randomized cross-over trial. Cancer Treatment Reviews. 10. 41–46. 24 indexed citations
18.
Neidhart, James A. & Ralph W. Roach. (1982). Successful treatment of skeletal hemangioma and kasabach-merritt syndrome with aminocaproic acid. The American Journal of Medicine. 73(3). 434–438. 33 indexed citations
19.
Meites, Samuel, et al.. (1974). Two Ultramicro-Scale Methods for Plasma Uric Acid Analysis with Uricase. Clinical Chemistry. 20(7). 790–793. 5 indexed citations
20.
Roach, Ralph W. & Vanessa M. Lopes. (1966). Mortality in adult ewes resulting from intestinal infestation with immature paramphistomes, complicated by severe fasciolasis.. PubMed. 14(3). 317–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026